Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of c-Myc using 10058-F4 induces anti-tumor effects in ovarian cancer cells via regulation of FOXO target genes
Roya Ghaffarnia, Ali Nasrollahzadeh, Davood Bashash, et al.
European Journal of Pharmacology (2021) Vol. 908, pp. 174345-174345
Closed Access | Times Cited: 17

Showing 17 citing articles:

Forkhead Box O Signaling Pathway in Skeletal Muscle Atrophy
Kun Chen, Peng Gao, Zongchao Li, et al.
American Journal Of Pathology (2022) Vol. 192, Iss. 12, pp. 1648-1657
Open Access | Times Cited: 61
Identification of a novel mechanism for reversal of doxorubicin-induced chemotherapy resistance by TXNIP in triple-negative breast cancer via promoting reactive oxygen-mediated DNA damage
Yi‐Ting Chen, Xueping Feng, Yuhao Yuan, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 36
Analysis of long Non-Coding RNA and mRNA expression in Clostridium butyricum-Induced apoptosis in SW480 colon cancer cells
Xiaorong Yang, Lan Wei
Gene (2025) Vol. 940, pp. 149208-149208
Closed Access
Co-targeting BMI1 and MYC to eliminate cancer stem cells in squamous cell carcinoma
Zhen Qin, Shuo Liu, Yunfei Zheng, et al.
Cell Reports Medicine (2025), pp. 102077-102077
Open Access
Hexavalent chromium caused DNA damage repair and apoptosis via the PI3K/AKT/FOXO1 pathway triggered by oxidative stress in the lung of rat
Lixia Zhang, Ningning Li, Xiuzhi Zhang, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 267, pp. 115622-115622
Open Access | Times Cited: 9
Pharmacological inhibition of MYC to mitigate chemoresistance in preclinical models of squamous cell carcinoma
Shuo Liu, Zhen Qin, Yaqing Mao, et al.
Theranostics (2023) Vol. 14, Iss. 2, pp. 622-639
Open Access | Times Cited: 9
Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma
Shuo Liu, Zhen Qin, Yaqing Mao, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 12
Role of O-GlcNAcylation on cancer stem cells: Connecting nutrient sensing to cell plasticity
Giang Lê Minh, Mauricio J. Reginato
Advances in cancer research (2022), pp. 195-228
Open Access | Times Cited: 10
Esomeprazole Alleviates Cisplatin Resistance by Inhibiting the AKT/mTOR Pathway in Ovarian Cancer Cells
Jingya Duan, Zisen Zhang, Jinfeng Du, et al.
OncoTargets and Therapy (2023) Vol. Volume 16, pp. 425-440
Open Access | Times Cited: 4
Anti-Leukemic Effects of Small Molecule Inhibitor of c-Myc (10058-F4) on Chronic Myeloid Leukemia Cells
Sara Zehtabcheh, Negar Sheikh‐Zeineddini, Amir-Mohammad Yousefi, et al.
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 6, pp. 1959-1967
Open Access | Times Cited: 1
C-Myc inhibition intensified the anti-leukemic properties of Imatinib in chronic myeloid leukemia cells
Sara Zehtabcheh, Amir‐Mohammad Yousefi, Majid Momeny, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 12, pp. 10157-10167
Closed Access | Times Cited: 3
Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis
Linzhang Li, Chengwu Han, Xueying Yu, et al.
Journal of Healthcare Engineering (2022) Vol. 2022, pp. 1-7
Open Access | Times Cited: 5
Micellar Curcumol for Maintenance Therapy of Ovarian Cancer by activating the FOXO3a
Jing Wang, Bing Chen, Jiezhen Yang, et al.
Research Square (Research Square) (2024)
Open Access
Micellar curcumol for maintenance therapy of ovarian cancer by activating the FOXO3a
Jing Wang, Bing Chen, Jiezhen Yang, et al.
Nanomedicine Nanotechnology Biology and Medicine (2024) Vol. 62, pp. 102789-102789
Open Access
Effect of MYC and PARP Inhibitors in Ovarian Cancer Using anIn VitroModel
Alessandro Morea, Sayeh Saravi, Cristina Sisu, et al.
Anticancer Research (2024) Vol. 44, Iss. 5, pp. 1817-1827
Open Access
The Activity of Trisindoline 5 Compound againsts c-Myc and FoxO1, 3, 4 Gene Expression on MDA-MB-231 Breast Cancer Stem Cells
Awik Puji Dyah Nurhayati, Muhammad Fatoni, Yofinta I Salsabila, et al.
Research Journal of Pharmacy and Technology (2024), pp. 5427-5434
Closed Access
NPM3 as an Unfavorable Prognostic Biomarker Involved in Oncogenic Pathways of Lung Adenocarcinoma via MYC Translational Activation
Long Chen, Demeng Yang, Fen Huang, et al.
Combinatorial Chemistry & High Throughput Screening (2023) Vol. 27, Iss. 2, pp. 203-213
Closed Access
RNA polymerase I subunit RPA43 activates rRNA expression and cell proliferation but inhibits cell migration
Yue Zhang, Yaoyu Pang, Kewei Zhang, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2023) Vol. 1867, Iss. 9, pp. 130411-130411
Open Access
Page 1

Scroll to top